Mitomycin C induced chromosomal aberrations in young cancer patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 422, Issue 2, 1998, Pages 223-228

  Bakshi, Sonal R ^a,c   Patel, Rashmi K ^a   Roy, Shambhu K ^a   Alladi, Phalguni ^a   Trivedi, Amit H ^a   Bhatavdekar, Jyotsna M ^a   Patel, Devendra D ^a   Shah, Pankaj M ^a   Rawal, Upendra M ^b  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b GUJARAT UNIVERSITY   (India)

^c Cell Biology Division   (India)

Author keywords

First degree relative; Mitomycin C induced chromosomal aberration; Mutagen sensitivity; Pediatric cancer patient

Indexed keywords

MITOMYCIN C;

ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MUTAGENICITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; CHROMATIDS; CHROMOSOME ABERRATIONS; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; MITOMYCIN; MUTAGENICITY TESTS; NEOPLASMS; REGRESSION ANALYSIS;

SAMBUCUS NIGRA CANADENSIS;

EID: 0032480952     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00197-3     Document Type: Article

References (28)

1. M. Sorsa, J. Wilbourn, H. Vainio, Human cytogenetic damage as a predictor of cancer risk, in: H. Vainio, P.N. Magee, D.B. McGregor, A.J. McMichael (Eds.), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publications, No. 116, International Agency for Research on Cancer, Lyon, 1992, pp. 543-554.
2. Hsu T.C. Genetic instability in the human population: a working hypothesis. Hereditas. 98:1983;1-9.
3. John Evans H. Mutation cytogenetics: past, present and future. Mutation Res. 204:1988;355-363.
4. Heim S., Johansson B., Mertens F. Constitutional chromosome instability and cancer risk. Mutation Res. 221:1989;39-51.
5. 2 chromatin radiosensitivity in predisposition to cancer. Int. J. Radiat. Biol. 55(6):1989;963-981.
6. Scott D., Spreadborough A., Levine E., Roberts S.A. Genetic predisposition in breast cancer. The Lancet. 344:1994;1444.
7. Johansson B., Mertens F. Frequency and distribution of mitomycin C-induced structural chromosome aberrations in lymphocytes from non-hodgkin's lymphoma patients. Cytogenet. Cell Genet. 48:1988;79-83.
8. Murty V.V.V.S., Mitra A.B., Sharma A., Das B.C., Luthra U.K. Mitomycin C-induced chromosomal aberrations and sister chromatid exchanges (SCEs) in lymphocytes of patients with precancerous and cancerous lesions of the uterine cervix. Neoplasma. 34:1987;101-105.
9. Qingyi W., Spitz R.M., Jun G., Cheng L., Xu X., Storm S.S., Kripke M.L., Hsu T.C. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiology Biomarkers and Prevention. 5:1996;199-204.
10. Cloos J., Steen I., Timmerman A.J., Van Der Schans G.P., Snow G.B., Braakhuis B.J.M. DNA-damage processing in blood lymphocytes of head-and-neck-squamous-cell-carcinoma patients is dependent on tumor site. Int. J. Cancer. 68:1996;26-29.
11. Fan S., Vijayalakshmi, Mindek G., Burkart W. Adaptive response to 2 low doses of X-rays in human blood lymphocytes. Mutation Res. 243(1):1990;53-56.
12. Adhvaryu S.G., Bhatt R.G., Dayal P.K., Trivedi A.H., Dave B.J., Vyas R.C., Jani K.H. SCE frequencies in lymphocytes of tobacco/betel nut chewers and patients with oral submucous fibrosis. Br. J. Cancer. 53:1986;141-143.
13. WHO, Guide to short term tests for detecting mutagenic and carcinogenic chemicals: Environmental health criteria 51, World Health Organization, Geneva, 1985, 57-67.
14. Hsu T.C., Lorraine M.C., Samaan N.A. Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet. Cytogenet. 17:1985;307-313.
15. Spitz M.R., Hoque A., Trizna Z., Schantz S.P., Christopher I.A., Terri M.K., Bondy M.L., Hong W.K., Hsu T.C. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J. Natl. Can. Inst. 86(22):1994;1681-1684.
16. Wiechselbaum R.R., Nove J., Little J.B. X-ray sensitivity of diploid fibroblasts from patients with hereditary or sporadic retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 75:1978;3962-3964.
17. 2 phase in normal and gardener syndrome fibroblasts. Interpretation in terms of deficient DNA repair. Mutation Res. 151:1985;57-63.
18. Caporaso N., Greene M.H., Tsui S., Williams Pickle L., Mulvihill J.J. Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet. Cytogenet. 24:1987;299-314.
19. Murty V.V.V.S., Mitra A.B., Luthra U.K. Spontaneous chromosomal aberrations in patients with precancerous and cancerous lesions of the cervix uteri. Cancer Genet. Cytogenet. 17:1985;347-354.
20. Mertens F., Johansson B. Frequency and distribution of N-methyl-N′-nitro-N-nitrosoguanidine (MNNG)-induced structural chromosome aberrations in fibroblasts from sarcoma and non-Hodgkin's lymphoma patients. Mutation Res. 210:1988;63-70.
21. Lambert B., Ringborg U., Skoog L. Age-related decrease of UV light-induced DNA repair synthesis in human peripheral leukocytes. Cancer Res. 39:1979;2792-2795.
22. de Nunez M., Penchaszadeh V.B., Pimentel E. Chromosome fragility in patients with sporadic unilateral retinoblastoma. Cancer Genet. Cytogenet. 11:1984;139-141.
23. E.J. Tawn, D. Holdsworth, Mutagen induced chromosome damage in human lymphocytes, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human cytogenetics Vol. II, Malignancy and acquired abnormalities, A practical approach, pp. 189-207.
24. Patel R.K., Trivesi A.H., Jaju R.J., Adhvaryu S.G., Balar D.B. Ethanol potentiates the clastogenicity of pan masala - an in vitro experience. Carcinogenesis. 15(9):1994;2017-2021.
25. Wiencke J.K., Spitz M.R. In vitro chromosomal assays of mutagen sensitivity and human cancer risk. The Cancer Bulletin. 46(3):1994;238-246.
26. Murname J.P. Role of induced genetic instability in the mutagenic effects of chemicals and radiation. Mutation Res. 367:1996;11-23.
27. Bonassi S., Abbondandolo A., Camurri L., Pra L.D., Ferrari M.D., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., Sbrana I., Vecchio D., Puntoni R. Are chromosome aberration in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 79:1995;133-135.
28. Brogger A., Hagmar L., Hansteen I., Heim S., Högstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I., Reuterwall C., Salomas S., Skerfving S., Sorsa M. An inter-nordic prospective study on cytogenetic endpoints and cancer risk. (The Nordic study group on the health risk of chromosome damage). Cancer Genet. Cytogenet. 45:1990;85-92.